NYSE$MCK
McKesson Corp · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
McKesson Corporation reported strong third quarter operational results with broad-based revenue growth and adjusted operating profit growth.
McKesson Corporation announced robust third-quarter results for fiscal year 2025, with consolidated revenues increasing by 18% to $95.3 billion and adjusted earnings per diluted share rising by 4% to $8.03. The company also raised its full-year adjusted EPS guidance, reflecting strong performance across its segments and strategic growth initiatives.
- Consolidated revenues increased by 18% to $95.3 billion.
- Adjusted Earnings per Diluted Share increased by 4% to $8.03.
- McKesson signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC.
- McKesson closed the transaction to sell its Canada-based Rexall and Well.ca retail businesses.
Headline financials
Revenue & EPS history
McKesson · Revenue · Quarterly
$95.3B
Revenue by segment
McKesson · $3.97B total across 2 segments · Q2 2024
- Medical-Surgical Solutions$2.83B-0.3%71.3%
- Prescription Technology Solutions$1.14B+12.0%28.7%
Forward guidance
McKesson is raising and narrowing its fiscal 2025 Adjusted Earnings per Diluted Share guidance range to $32.55 to $32.95, indicating 19% to 20% growth compared to the prior year.
Tailwinds
- Raised and narrowed fiscal 2025 Adjusted Earnings per Diluted Share guidance range to $32.55 to $32.95.
- Guidance indicates 19% to 20% growth compared to prior year.
- Strong third quarter performance provides a foundation for balanced growth and value creation.
- Continued commitment to enterprise growth strategy, including pillars within oncology and biopharma services.
- Fiscal 2025 Adjusted Earnings per Diluted Share guidance includes $0.57 related to year-to-date gains associated with McKesson Ventures' equity investments.
Headwinds
- The company does not forecast GAAP earnings per diluted share due to inherent uncertainties.
- Unable to provide quantitative reconciliation of forward-looking Non-GAAP measures to GAAP without unreasonable effort.
- Difficult to predict and estimate LIFO inventory-related adjustments.
- Uncertainty regarding certain litigation loss and gain contingencies.
- Restructuring, impairment, and related charges are difficult to forecast.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+1.2%
Avg return
Earnings day
+0.6%
Avg return
5 days after
+1.1%
Avg return
30 days after
60%
44 / 73 earnings
Positive
+16.5%
Q3 2026
Best reaction
-21.7%
Q2 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +0.2% | -3.4% | +2.8% | |
| Q3 2026 | +16.5% | +13.8% | +11.8% | |
| Q2 2026 | +1.5% | +1.4% | -4.2% | |
| Q1 2026 | -5.8% | -6.4% | -2.3% | |
| Q4 2025 | +0.4% | -1.2% | +3.3% | |
| Q3 2025 | -1.2% | +0.6% | +6.1% | |
| Q2 2025 | +15.7% | +17.2% | +14.9% | |
| Q1 2025 | -10.9% | -10.3% | -17.9% | |
| Q4 2024 | +1.9% | +5.0% | +9.9% | |
| Q3 2024 | -2.5% | -2.4% | +4.1% | |
| Q2 2024 | -1.7% | +1.0% | +2.0% | |
| Q1 2024 | +7.4% | +4.2% | +1.8% | |
| Q4 2023 | +6.2% | +6.6% | +5.1% | |
| Q3 2023 | -3.2% | -5.4% | -8.7% | |
| Q2 2023 | +0.1% | +1.9% | -2.5% | |
| Q1 2023 | +0.8% | +3.7% | +8.6% | |
| Q4 2022 | +4.5% | +3.1% | -1.1% | |
| Q3 2022 | +4.1% | +5.2% | +9.7% | |
| Q2 2022 | +5.3% | +6.6% | +3.6% | |
| Q1 2022 | -3.3% | -4.6% | -0.1% | |
| Q4 2021 | +4.5% | +4.7% | +3.1% | |
| Q3 2021 | +1.0% | +1.9% | -4.1% | |
| Q2 2021 | +9.2% | +12.4% | +17.8% | |
| Q1 2021 | +4.6% | +1.2% | +4.1% | |
| Q4 2020 | +0.8% | +3.3% | +8.3% | |
| Q3 2020 | +5.7% | +8.6% | +0.8% | |
| Q2 2020 | -11.0% | -7.9% | -3.2% | |
| Q1 2020 | +4.0% | +1.5% | -3.0% | |
| Q4 2019 | +7.1% | +0.6% | +3.7% | |
| Q3 2019 | +1.9% | +5.4% | -0.4% | |
| Q2 2019 | -2.6% | +2.1% | -0.3% | |
| Q1 2019 | -7.1% | -5.8% | -2.8% | |
| Q4 2018 | -0.7% | -3.8% | +1.4% | |
| Q3 2018 | -5.7% | -9.7% | -11.2% | |
| Q2 2018 | -10.4% | -8.9% | -4.4% | |
| Q1 2018 | -2.3% | -3.1% | -11.3% | |
| Q4 2017 | +7.7% | +11.9% | +12.5% | |
| Q3 2017 | -6.6% | -7.6% | +1.7% | |
| Q2 2017 | -21.7% | -18.5% | -9.8% | |
| Q1 2017 | -1.4% | -2.1% | -6.9% | |
| Q4 2016 | +2.7% | — | — | |
| Q3 2016 | -6.4% | — | — | |
| Q2 2016 | -2.0% | — | — | |
| Q1 2016 | -4.1% | — | — | |
| Q4 2015 | +1.7% | — | — | |
| Q3 2015 | +5.7% | — | — | |
| Q2 2015 | -2.1% | — | — | |
| Q1 2015 | +2.2% | — | — | |
| Q4 2014 | +5.3% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +8.3% | — | — | |
| Q1 2014 | +5.4% | — | — | |
| Q4 2013 | +7.3% | — | — | |
| Q3 2013 | -2.3% | — | — | |
| Q2 2013 | +3.4% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | -0.7% | — | — | |
| Q3 2012 | +3.0% | — | — | |
| Q2 2012 | +6.3% | — | — | |
| Q1 2012 | +0.7% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q3 2011 | +2.3% | — | — | |
| Q2 2011 | +6.0% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2008 | +3.8% | — | — | |
| Q4 2010 | +3.8% | — | — | |
| Q3 2010 | -3.1% | — | — | |
| Q3 2009 | -3.1% | — | — | |
| Q2 2010 | -3.2% | — | — | |
| Q2 2009 | +8.9% | — | — | |
| Q1 2009 | +8.9% | — | — | |
| Q1 2010 | +8.9% | — | — | |
| Q4 2009 | +8.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro